loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about ONC201, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    ONC201

    DEVELOPMENTS

    PharmaCompass

    Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    2D Structure
    1. Also known as: 1616632-77-9, Onc 201, Onc-201, Onc201, Nsc-350625, 9u35a31jai
    Molecular Formula
    C24H26N4O
    Molecular Weight
    386.5  g/mol
    InChI Key
    VLULRUCCHYVXOH-UHFFFAOYSA-N
    FDA UNII
    9U35A31JAI
    Akt/ERK Inhibitor ONC201 is a water soluble, orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) and extracellular signal-regulated kinase (ERK), with potential antineoplastic activity. Upon administration, Akt/ERK inhibitor ONC201 binds to and inhibits the activity of Akt and ERK, which may result in inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt signal transduction pathway as well as the mitogen-activated protein kinase (MAPK)/ERK-mediated pathway. This may lead to the induction of tumor cell apoptosis mediated by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/TRAIL death receptor type 5 (DR5) signaling in AKT/ERK-overexpressing tumor cells. The PI3K/Akt signaling pathway and MAPK/ERK pathway are upregulated in a variety of tumor cell types and play a key role in tumor cell proliferation, differentiation and survival by inhibiting apoptosis. In addition, ONC201 is able to cross the blood-brain barrier.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one
    2.1.2 InChI
    InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-23(29)21-17-26(15-19-8-3-2-4-9-19)13-11-22(21)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3
    2.1.3 InChI Key
    VLULRUCCHYVXOH-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5
    2.2 Other Identifiers
    2.2.1 UNII
    9U35A31JAI
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(4h)-one

    2. Onc201

    3. Tic10 Compound

    4. Trail-inducing Compound 10

    2.3.2 Depositor-Supplied Synonyms

    1. 1616632-77-9

    2. Onc 201

    3. Onc-201

    4. Onc201

    5. Nsc-350625

    6. 9u35a31jai

    7. Mfcd28118993

    8. 11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one

    9. 1342897-86-2

    10. Active Isomer 2

    11. Tic10 Compound

    12. 7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(4h)-one

    13. Angular Tic10

    14. Tic10 Active Isomer

    15. Unii-9u35a31jai

    16. Gtpl9978

    17. Tic10?

    18. Chembl4297310

    19. Onc 201 [who-dd]

    20. Schembl16227974

    21. Ex-a669

    22. Hms3874g13

    23. Bcp14991

    24. Hy-15615a

    25. Nsc784931

    26. S7963

    27. Zinc169620396

    28. Ccg-264705

    29. Cs-3564

    30. Db14844

    31. Nsc 350625

    32. Nsc-784931

    33. Sb17110

    34. Ncgc00386747-03

    35. Ncgc00386747-06

    36. Ncgc00386747-09

    37. Ncgc00386747-10

    38. As-16735

    39. Sy242153

    40. Ft-0700231

    41. A883070

    42. J-690224

    43. Q27895916

    44. 2,4,6,7,8,9-hexahydro-4-((2-methylphenyl)methyl)-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one

    45. 2,4,6,7,8,9-hexahydro-4-((2-methylphenyl)methyl)-7-phenylmethyl)imidazo)(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one

    2.4 Create Date
    2014-05-26
    3 Chemical and Physical Properties
    Molecular Weight 386.5 g/mol
    Molecular Formula C24H26N4O
    XLogP32.3
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count4
    Exact Mass386.21066147 g/mol
    Monoisotopic Mass386.21066147 g/mol
    Topological Polar Surface Area39.2 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity693
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antineoplastic Agents

    Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

    Post Enquiry
    POST ENQUIRY